0001601830-20-000002.txt : 20201112 0001601830-20-000002.hdr.sgml : 20201112 20201112132044 ACCESSION NUMBER: 0001601830-20-000002 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20201112 DATE AS OF CHANGE: 20201112 EFFECTIVENESS DATE: 20201112 FILER: COMPANY DATA: COMPANY CONFORMED NAME: RECURSION PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0001601830 IRS NUMBER: 464099738 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-375551 FILM NUMBER: 201305440 BUSINESS ADDRESS: STREET 1: 41S RIO GRANDE STREET CITY: SALT LAKE CITY STATE: UT ZIP: 84101 BUSINESS PHONE: (385) 269-0203 MAIL ADDRESS: STREET 1: 41S RIO GRANDE STREET CITY: SALT LAKE CITY STATE: UT ZIP: 84101 FORMER COMPANY: FORMER CONFORMED NAME: Recursion Pharmaceuticals, LLC DATE OF NAME CHANGE: 20140305 D/A 1 primary_doc.xml X0708 D/A LIVE 0001601830 RECURSION PHARMACEUTICALS, INC. 41S RIO GRANDE STREET SALT LAKE CITY UT UTAH 84101 (385) 269-0203 DELAWARE Recursion Pharmaceuticals, LLC Corporation true CHRISTOPHER C. GIBSON 41S RIO GRANDE STREET SALT LAKE CITY UT UTAH 84101 Executive Officer Director Promoter BLAKE C. BORGESON 41S RIO GRANDE STREET SALT LAKE CITY UT UTAH 84101 Director ZAVAIN DAR 1600 EL CAMINO REAL SUITE 290 MENLO PARK CA CALIFORNIA 94025 Director ZACHARY BOGUE 317 UNIVERSITY AVENUE SUITE 200 PALO ALTO CA CALIFORNIA 94301 Director DEAN LI 41S RIO GRANDE STREET SALT LAKE CITY UT UTAH 84101 Director ROBERT HERSHBERG 41S RIO GRANDE STREET SALT LAKE CITY UT UTAH 84101 Director TERRY-ANN BURRELL 41S RIO GRANDE STREET SALT LAKE CITY UT UTAH 84101 Director R. MARTIN CHAVEZ 41S RIO GRANDE STREET SALT LAKE CITY UT UTAH 84101 Director MICHAEL SECORA 41S RIO GRANDE STREET SALT LAKE CITY UT UTAH 84101 Executive Officer Promoter Pharmaceuticals Decline to Disclose 06b true 0001601830-20-000001 2020-09-01 false true false 0 245896677 245896677 0 false 49 0 0 0 false RECURSION PHARMACEUTICALS, INC. /s/ Christopher C. Gibson Christopher C. Gibson Chief Executive Officer 2020-11-11